| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Salmonella typhimurium | 39 | 2019 | 82 | 7.720 |
Why?
|
| Intestinal Mucosa | 43 | 2022 | 224 | 7.070 |
Why?
|
| Neutrophils | 39 | 2021 | 353 | 5.940 |
Why?
|
| Bacterial Proteins | 31 | 2021 | 732 | 4.750 |
Why?
|
| Gastrointestinal Microbiome | 14 | 2024 | 203 | 4.120 |
Why?
|
| Epithelial Cells | 27 | 2021 | 384 | 4.080 |
Why?
|
| Host-Pathogen Interactions | 13 | 2019 | 236 | 3.640 |
Why?
|
| Cell Movement | 23 | 2021 | 428 | 3.140 |
Why?
|
| Neutrophil Infiltration | 12 | 2019 | 60 | 3.070 |
Why?
|
| Salmonella Infections | 13 | 2019 | 38 | 2.970 |
Why?
|
| Microfilament Proteins | 10 | 2017 | 108 | 2.460 |
Why?
|
| Shigella flexneri | 13 | 2017 | 19 | 2.260 |
Why?
|
| Microbiota | 5 | 2022 | 104 | 2.250 |
Why?
|
| Dysbiosis | 8 | 2022 | 57 | 2.080 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 13 | 2019 | 21 | 2.060 |
Why?
|
| Frailty | 3 | 2021 | 124 | 1.750 |
Why?
|
| Caspase 3 | 6 | 2019 | 103 | 1.750 |
Why?
|
| Intestines | 14 | 2021 | 158 | 1.650 |
Why?
|
| Inflammation | 19 | 2024 | 1094 | 1.600 |
Why?
|
| Multidrug Resistance-Associated Proteins | 5 | 2018 | 11 | 1.550 |
Why?
|
| Dysentery, Bacillary | 6 | 2021 | 14 | 1.530 |
Why?
|
| Escherichia coli | 13 | 2022 | 693 | 1.440 |
Why?
|
| Bacteria | 7 | 2021 | 279 | 1.430 |
Why?
|
| Transendothelial and Transepithelial Migration | 9 | 2019 | 12 | 1.330 |
Why?
|
| Shigella | 4 | 2021 | 8 | 1.200 |
Why?
|
| Bacterial Adhesion | 11 | 2017 | 58 | 1.190 |
Why?
|
| Membrane Proteins | 11 | 2022 | 846 | 1.180 |
Why?
|
| Lung | 5 | 2018 | 913 | 1.130 |
Why?
|
| Chemotactic Factors | 7 | 2021 | 26 | 1.110 |
Why?
|
| Escherichia coli Infections | 8 | 2022 | 85 | 1.070 |
Why?
|
| Cell Line | 22 | 2019 | 1968 | 1.070 |
Why?
|
| Arachidonate 12-Lipoxygenase | 8 | 2019 | 13 | 1.050 |
Why?
|
| Animals | 59 | 2024 | 19601 | 1.050 |
Why?
|
| Humans | 90 | 2024 | 59282 | 1.030 |
Why?
|
| Signal Transduction | 20 | 2018 | 2888 | 1.020 |
Why?
|
| Fimbriae, Bacterial | 7 | 2017 | 19 | 0.990 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2017 | 178 | 0.980 |
Why?
|
| Pseudomonas aeruginosa | 4 | 2012 | 99 | 0.970 |
Why?
|
| Alzheimer Disease | 5 | 2024 | 679 | 0.940 |
Why?
|
| Virulence Factors | 8 | 2019 | 80 | 0.920 |
Why?
|
| Mice | 36 | 2024 | 10251 | 0.830 |
Why?
|
| Chemotaxis, Leukocyte | 7 | 2011 | 62 | 0.790 |
Why?
|
| Group IV Phospholipases A2 | 3 | 2017 | 5 | 0.730 |
Why?
|
| Salmonella | 4 | 2017 | 37 | 0.730 |
Why?
|
| Phospholipases A2 | 3 | 2010 | 12 | 0.730 |
Why?
|
| Pneumococcal Infections | 3 | 2019 | 35 | 0.720 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2021 | 87 | 0.710 |
Why?
|
| Bacterial Infections | 5 | 2023 | 140 | 0.700 |
Why?
|
| Pseudomonas Infections | 3 | 2012 | 51 | 0.690 |
Why?
|
| Immunity, Mucosal | 5 | 2010 | 48 | 0.690 |
Why?
|
| Respiratory Mucosa | 3 | 2018 | 53 | 0.680 |
Why?
|
| Cell Line, Tumor | 9 | 2017 | 1368 | 0.670 |
Why?
|
| Precision Medicine | 1 | 2020 | 102 | 0.660 |
Why?
|
| Drug Resistance, Multiple | 2 | 2017 | 33 | 0.660 |
Why?
|
| Genetic Engineering | 2 | 2017 | 111 | 0.640 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 263 | 0.640 |
Why?
|
| Salmonella Infections, Animal | 3 | 2010 | 9 | 0.640 |
Why?
|
| Enterocolitis | 2 | 2009 | 3 | 0.630 |
Why?
|
| Disease Models, Animal | 10 | 2022 | 2046 | 0.620 |
Why?
|
| Enteritis | 3 | 2009 | 13 | 0.620 |
Why?
|
| Endocannabinoids | 1 | 2018 | 20 | 0.600 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2018 | 26 | 0.600 |
Why?
|
| Intestinal Diseases | 2 | 2008 | 34 | 0.590 |
Why?
|
| Glycoproteins | 1 | 2019 | 186 | 0.570 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2017 | 4 | 0.570 |
Why?
|
| Mucin-1 | 1 | 2017 | 14 | 0.560 |
Why?
|
| Cadaverine | 3 | 2002 | 3 | 0.560 |
Why?
|
| Pneumonia, Bacterial | 2 | 2017 | 88 | 0.560 |
Why?
|
| Nutritional Status | 1 | 2017 | 93 | 0.550 |
Why?
|
| Tight Junctions | 4 | 2017 | 20 | 0.550 |
Why?
|
| Immunity, Innate | 8 | 2021 | 765 | 0.540 |
Why?
|
| Neoplasms | 3 | 2020 | 1240 | 0.540 |
Why?
|
| Cecum | 5 | 2008 | 13 | 0.530 |
Why?
|
| Aging | 2 | 2023 | 710 | 0.510 |
Why?
|
| Colon | 5 | 2024 | 136 | 0.500 |
Why?
|
| Protein Kinase C | 6 | 2011 | 98 | 0.500 |
Why?
|
| Cell Polarity | 10 | 2005 | 109 | 0.490 |
Why?
|
| Models, Biological | 7 | 2018 | 1140 | 0.480 |
Why?
|
| Feces | 5 | 2024 | 97 | 0.460 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 215 | 0.460 |
Why?
|
| Glutathione Peroxidase | 1 | 2014 | 27 | 0.450 |
Why?
|
| Metal Nanoparticles | 1 | 2016 | 182 | 0.430 |
Why?
|
| Phosphorylation | 8 | 2017 | 882 | 0.430 |
Why?
|
| Gene Expression Regulation, Bacterial | 4 | 2011 | 149 | 0.430 |
Why?
|
| Virulence | 11 | 2014 | 186 | 0.430 |
Why?
|
| Gastrointestinal Diseases | 2 | 2012 | 69 | 0.420 |
Why?
|
| Inflammation Mediators | 2 | 2007 | 168 | 0.420 |
Why?
|
| Eicosanoids | 2 | 2010 | 25 | 0.420 |
Why?
|
| Homeostasis | 3 | 2021 | 346 | 0.410 |
Why?
|
| Interleukin-8 | 10 | 2008 | 86 | 0.410 |
Why?
|
| Peyer's Patches | 3 | 2009 | 35 | 0.410 |
Why?
|
| Cells, Cultured | 13 | 2017 | 2089 | 0.410 |
Why?
|
| Bacterial Toxins | 3 | 2019 | 60 | 0.400 |
Why?
|
| Arachidonic Acid | 4 | 2017 | 34 | 0.400 |
Why?
|
| Clostridium Infections | 2 | 2024 | 45 | 0.390 |
Why?
|
| Cognitive Dysfunction | 3 | 2024 | 309 | 0.380 |
Why?
|
| Bacterial Secretion Systems | 1 | 2011 | 10 | 0.380 |
Why?
|
| Pseudopodia | 1 | 2011 | 12 | 0.370 |
Why?
|
| Nursing Homes | 4 | 2024 | 661 | 0.370 |
Why?
|
| Mice, Knockout | 7 | 2024 | 1985 | 0.370 |
Why?
|
| Nanoparticles | 1 | 2017 | 493 | 0.360 |
Why?
|
| Human Development | 2 | 2020 | 9 | 0.360 |
Why?
|
| Enzyme Inhibitors | 6 | 2017 | 349 | 0.360 |
Why?
|
| Health | 2 | 2020 | 31 | 0.360 |
Why?
|
| Salmonella enterica | 2 | 2008 | 26 | 0.350 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 196 | 0.340 |
Why?
|
| Molecular Targeted Therapy | 1 | 2010 | 120 | 0.340 |
Why?
|
| Gastrointestinal Tract | 1 | 2012 | 170 | 0.340 |
Why?
|
| Protein Transport | 5 | 2016 | 394 | 0.330 |
Why?
|
| Streptococcus pneumoniae | 3 | 2019 | 62 | 0.330 |
Why?
|
| Muramidase | 1 | 2009 | 46 | 0.330 |
Why?
|
| Probiotics | 3 | 2020 | 44 | 0.320 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2022 | 95 | 0.320 |
Why?
|
| HeLa Cells | 9 | 2019 | 523 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 3220 | 0.300 |
Why?
|
| Intestinal Neoplasms | 1 | 2008 | 13 | 0.300 |
Why?
|
| Dementia | 2 | 2023 | 248 | 0.300 |
Why?
|
| Saccharomyces | 1 | 2007 | 3 | 0.290 |
Why?
|
| Mutation | 9 | 2019 | 2452 | 0.290 |
Why?
|
| Anti-Bacterial Agents | 4 | 2024 | 730 | 0.290 |
Why?
|
| Diarrhea | 3 | 2017 | 74 | 0.290 |
Why?
|
| Streptomycin | 5 | 2008 | 12 | 0.280 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 85 | 0.280 |
Why?
|
| Enterobacteriaceae | 3 | 2022 | 14 | 0.270 |
Why?
|
| Crohn Disease | 1 | 2008 | 105 | 0.260 |
Why?
|
| Cell Membrane | 5 | 2019 | 484 | 0.260 |
Why?
|
| Aged | 8 | 2024 | 13412 | 0.260 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 656 | 0.260 |
Why?
|
| Antimicrobial Cationic Peptides | 3 | 2020 | 51 | 0.260 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2023 | 78 | 0.260 |
Why?
|
| Phospholipases A | 1 | 2005 | 11 | 0.250 |
Why?
|
| Blotting, Western | 3 | 2014 | 583 | 0.250 |
Why?
|
| Female | 17 | 2024 | 30695 | 0.250 |
Why?
|
| Drug Delivery Systems | 3 | 2017 | 311 | 0.240 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2016 | 70 | 0.240 |
Why?
|
| Amino Acid Motifs | 2 | 2019 | 150 | 0.240 |
Why?
|
| Succinic Acid | 1 | 2024 | 11 | 0.240 |
Why?
|
| Hyperplasia | 1 | 2024 | 84 | 0.230 |
Why?
|
| Colitis | 2 | 2021 | 75 | 0.230 |
Why?
|
| Male | 17 | 2024 | 27727 | 0.230 |
Why?
|
| Cognitive Aging | 1 | 2023 | 4 | 0.220 |
Why?
|
| Antigen Presentation | 1 | 2006 | 223 | 0.220 |
Why?
|
| Plasmids | 4 | 2017 | 279 | 0.220 |
Why?
|
| Chemokines | 3 | 1999 | 92 | 0.210 |
Why?
|
| Actins | 4 | 2016 | 258 | 0.210 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 5128 | 0.200 |
Why?
|
| Cytokines | 5 | 2024 | 904 | 0.200 |
Why?
|
| Goblet Cells | 1 | 2022 | 8 | 0.200 |
Why?
|
| Adhesins, Escherichia coli | 2 | 2012 | 3 | 0.200 |
Why?
|
| Butyrates | 1 | 2022 | 15 | 0.200 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 20 | 0.200 |
Why?
|
| Piperidines | 1 | 2002 | 54 | 0.200 |
Why?
|
| Escherichia coli Proteins | 3 | 2007 | 264 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 4 | 2017 | 868 | 0.190 |
Why?
|
| Diet | 2 | 2022 | 497 | 0.190 |
Why?
|
| Hyperglycemia | 1 | 2022 | 98 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 205 | 0.190 |
Why?
|
| Vacuoles | 2 | 2011 | 26 | 0.190 |
Why?
|
| Insulins | 1 | 2022 | 15 | 0.190 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2001 | 20 | 0.190 |
Why?
|
| Diet, High-Fat | 1 | 2022 | 163 | 0.190 |
Why?
|
| Phagosomes | 1 | 2001 | 43 | 0.190 |
Why?
|
| Prospective Studies | 2 | 2019 | 3065 | 0.180 |
Why?
|
| Interleukin-6 | 1 | 2002 | 308 | 0.180 |
Why?
|
| Digestive System Diseases | 1 | 2020 | 14 | 0.180 |
Why?
|
| Mammals | 1 | 2022 | 208 | 0.180 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 18 | 0.180 |
Why?
|
| Ubiquitination | 1 | 2021 | 106 | 0.180 |
Why?
|
| Immune System Diseases | 1 | 2020 | 17 | 0.180 |
Why?
|
| Myeloid Cells | 1 | 2021 | 89 | 0.180 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 54 | 0.170 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2019 | 3 | 0.170 |
Why?
|
| Streptolysins | 1 | 2019 | 8 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2011 | 39 | 0.170 |
Why?
|
| Carboxy-Lyases | 1 | 1999 | 6 | 0.170 |
Why?
|
| Arachidonic Acids | 2 | 2011 | 23 | 0.170 |
Why?
|
| Down-Regulation | 3 | 2017 | 305 | 0.160 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2020 | 52 | 0.160 |
Why?
|
| Cell Migration Assays, Leukocyte | 2 | 2009 | 2 | 0.160 |
Why?
|
| Metagenomics | 1 | 2019 | 22 | 0.160 |
Why?
|
| Bacteremia | 2 | 2017 | 90 | 0.160 |
Why?
|
| Bacterial Load | 1 | 2019 | 28 | 0.160 |
Why?
|
| Incidence | 1 | 2022 | 1236 | 0.160 |
Why?
|
| Lipopolysaccharides | 1 | 2002 | 626 | 0.150 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 631 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 86 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 74 | 0.150 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2018 | 9 | 0.150 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 37 | 0.150 |
Why?
|
| Peptic Ulcer Perforation | 1 | 2018 | 5 | 0.150 |
Why?
|
| Longitudinal Studies | 2 | 2023 | 1189 | 0.150 |
Why?
|
| Protein Kinase C-alpha | 2 | 2011 | 16 | 0.150 |
Why?
|
| Carbazoles | 2 | 2011 | 13 | 0.150 |
Why?
|
| Microvilli | 2 | 2016 | 4 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2011 | 43 | 0.150 |
Why?
|
| Protein Domains | 1 | 2019 | 139 | 0.150 |
Why?
|
| Chlorobenzoates | 1 | 2017 | 1 | 0.150 |
Why?
|
| ortho-Aminobenzoates | 1 | 2017 | 7 | 0.150 |
Why?
|
| Cinnamates | 1 | 2017 | 8 | 0.150 |
Why?
|
| Cell Communication | 2 | 2010 | 122 | 0.150 |
Why?
|
| Cyclohexanones | 1 | 2017 | 5 | 0.150 |
Why?
|
| Tetrathionic Acid | 1 | 2017 | 1 | 0.150 |
Why?
|
| Antibiosis | 1 | 2017 | 3 | 0.140 |
Why?
|
| Insurance Coverage | 1 | 2018 | 94 | 0.140 |
Why?
|
| Dinoprostone | 2 | 2023 | 44 | 0.140 |
Why?
|
| Machine Learning | 1 | 2019 | 153 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 445 | 0.140 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 1997 | 2 | 0.140 |
Why?
|
| Adhesins, Bacterial | 1 | 1997 | 9 | 0.140 |
Why?
|
| Permeability | 1 | 2017 | 49 | 0.140 |
Why?
|
| Structure-Activity Relationship | 2 | 2017 | 363 | 0.140 |
Why?
|
| Integrin beta1 | 1 | 1997 | 28 | 0.140 |
Why?
|
| Insurance, Health | 1 | 2018 | 133 | 0.140 |
Why?
|
| Enzyme Activation | 3 | 2010 | 358 | 0.140 |
Why?
|
| Nanomedicine | 1 | 2017 | 24 | 0.140 |
Why?
|
| Macrophages | 3 | 2017 | 1000 | 0.130 |
Why?
|
| Protein Structure, Secondary | 1 | 2017 | 253 | 0.130 |
Why?
|
| Nitric Oxide | 1 | 2017 | 146 | 0.130 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2016 | 2 | 0.130 |
Why?
|
| Survival Analysis | 1 | 2017 | 555 | 0.130 |
Why?
|
| Type III Secretion Systems | 1 | 2016 | 4 | 0.130 |
Why?
|
| NF-kappa B | 2 | 2008 | 458 | 0.130 |
Why?
|
| Doxorubicin | 1 | 2016 | 97 | 0.130 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2016 | 27 | 0.130 |
Why?
|
| Zonula Occludens-1 Protein | 3 | 2007 | 7 | 0.130 |
Why?
|
| Receptors, Chemokine | 2 | 2006 | 36 | 0.120 |
Why?
|
| Actin Cytoskeleton | 1 | 2016 | 75 | 0.120 |
Why?
|
| Gene Deletion | 4 | 2009 | 292 | 0.120 |
Why?
|
| Amino Acid Sequence | 5 | 2010 | 1552 | 0.120 |
Why?
|
| RNA, Small Interfering | 2 | 2011 | 855 | 0.120 |
Why?
|
| Chemotaxis | 3 | 2007 | 48 | 0.120 |
Why?
|
| Fimbriae Proteins | 2 | 2005 | 13 | 0.120 |
Why?
|
| Molecular Sequence Data | 5 | 2010 | 1949 | 0.120 |
Why?
|
| HEK293 Cells | 1 | 2017 | 586 | 0.120 |
Why?
|
| Base Sequence | 3 | 2010 | 1300 | 0.120 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2015 | 65 | 0.120 |
Why?
|
| Cell Death | 1 | 2016 | 271 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2017 | 175 | 0.120 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2022 | 84 | 0.120 |
Why?
|
| Extracellular Matrix | 1 | 1995 | 132 | 0.120 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 68 | 0.120 |
Why?
|
| Enterohemorrhagic Escherichia coli | 1 | 2014 | 13 | 0.110 |
Why?
|
| Genetic Complementation Test | 3 | 2009 | 62 | 0.110 |
Why?
|
| Phosphoproteins | 3 | 2007 | 211 | 0.110 |
Why?
|
| Immune Evasion | 1 | 2014 | 55 | 0.110 |
Why?
|
| Arachidonate 15-Lipoxygenase | 2 | 2017 | 8 | 0.110 |
Why?
|
| Gold | 1 | 2016 | 225 | 0.110 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2024 | 17 | 0.110 |
Why?
|
| Cell Migration Inhibition | 2 | 2004 | 7 | 0.110 |
Why?
|
| Genomic Islands | 2 | 2011 | 8 | 0.110 |
Why?
|
| Peptides | 1 | 2017 | 547 | 0.110 |
Why?
|
| Tuberculosis | 1 | 2017 | 270 | 0.110 |
Why?
|
| Mucus | 3 | 2000 | 15 | 0.110 |
Why?
|
| Shiga-Toxigenic Escherichia coli | 1 | 2013 | 7 | 0.110 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2013 | 21 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 201 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 2 | 2007 | 450 | 0.100 |
Why?
|
| Blood-Air Barrier | 1 | 2012 | 1 | 0.100 |
Why?
|
| Protein Kinase C-delta | 1 | 2012 | 6 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 390 | 0.100 |
Why?
|
| Integrases | 1 | 1993 | 36 | 0.100 |
Why?
|
| Protein Binding | 2 | 2015 | 1554 | 0.100 |
Why?
|
| Biological Transport | 2 | 2004 | 288 | 0.100 |
Why?
|
| Dendritic Cells | 2 | 2006 | 507 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 806 | 0.100 |
Why?
|
| Cell Proliferation | 1 | 2016 | 940 | 0.100 |
Why?
|
| Benzophenanthridines | 1 | 2011 | 2 | 0.100 |
Why?
|
| Cytoplasm | 2 | 2010 | 270 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2001 | 1151 | 0.100 |
Why?
|
| Transplantation, Heterologous | 2 | 2012 | 223 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2018 | 1202 | 0.090 |
Why?
|
| Epithelium | 3 | 1997 | 96 | 0.090 |
Why?
|
| 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 2010 | 1 | 0.090 |
Why?
|
| Transfection | 2 | 2011 | 675 | 0.090 |
Why?
|
| Gastroenteritis | 1 | 2010 | 12 | 0.090 |
Why?
|
| Mice, SCID | 2 | 2012 | 512 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 126 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2010 | 103 | 0.090 |
Why?
|
| Claudin-1 | 2 | 2007 | 3 | 0.080 |
Why?
|
| Occludin | 2 | 2007 | 3 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 256 | 0.080 |
Why?
|
| Serum Albumin | 1 | 1989 | 45 | 0.080 |
Why?
|
| Cadherins | 2 | 2007 | 69 | 0.080 |
Why?
|
| Species Specificity | 2 | 2008 | 328 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 289 | 0.080 |
Why?
|
| Middle Aged | 5 | 2023 | 16310 | 0.080 |
Why?
|
| Apoptosis | 1 | 2014 | 1032 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 2 | 2001 | 390 | 0.080 |
Why?
|
| Chemokines, CXC | 1 | 2008 | 29 | 0.080 |
Why?
|
| Nod1 Signaling Adaptor Protein | 1 | 2008 | 12 | 0.080 |
Why?
|
| Retinoblastoma Protein | 1 | 2008 | 37 | 0.080 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 169 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2008 | 59 | 0.070 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2008 | 6 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 127 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2008 | 136 | 0.070 |
Why?
|
| Genes, Bacterial | 3 | 2007 | 116 | 0.070 |
Why?
|
| Leukotriene B4 | 1 | 2007 | 13 | 0.070 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2007 | 3 | 0.070 |
Why?
|
| Collagen Type I | 1 | 2008 | 38 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2008 | 53 | 0.070 |
Why?
|
| Immediate-Early Proteins | 1 | 2008 | 44 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2008 | 606 | 0.070 |
Why?
|
| Colony Count, Microbial | 1 | 2007 | 56 | 0.070 |
Why?
|
| Electric Impedance | 1 | 2007 | 35 | 0.070 |
Why?
|
| Quinolinic Acids | 1 | 2007 | 2 | 0.070 |
Why?
|
| Dogs | 3 | 2008 | 314 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1051 | 0.070 |
Why?
|
| Fibrosis | 1 | 2008 | 153 | 0.070 |
Why?
|
| Bacillus subtilis | 2 | 2019 | 32 | 0.070 |
Why?
|
| NAD | 1 | 2007 | 50 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 151 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2008 | 365 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 1204 | 0.070 |
Why?
|
| Time Factors | 4 | 2008 | 3614 | 0.070 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2008 | 16 | 0.070 |
Why?
|
| Bacterial Typing Techniques | 1 | 2006 | 13 | 0.060 |
Why?
|
| Mucous Membrane | 1 | 2006 | 20 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2008 | 377 | 0.060 |
Why?
|
| Nematospiroides dubius | 1 | 2005 | 4 | 0.060 |
Why?
|
| Strongylida Infections | 1 | 2005 | 5 | 0.060 |
Why?
|
| Citrobacter rodentium | 1 | 2005 | 5 | 0.060 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2006 | 121 | 0.060 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2005 | 10 | 0.060 |
Why?
|
| Swine Diseases | 1 | 2005 | 3 | 0.060 |
Why?
|
| Enterotoxins | 1 | 2005 | 20 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2007 | 400 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2006 | 220 | 0.060 |
Why?
|
| Equol | 1 | 2024 | 5 | 0.060 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 44 | 0.060 |
Why?
|
| Cytosol | 1 | 2005 | 170 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2008 | 716 | 0.060 |
Why?
|
| Metabolomics | 1 | 2024 | 49 | 0.060 |
Why?
|
| Membranes | 1 | 2004 | 19 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 67 | 0.060 |
Why?
|
| Culture Techniques | 1 | 2003 | 12 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 688 | 0.060 |
Why?
|
| Hydroxy Acids | 1 | 2023 | 2 | 0.050 |
Why?
|
| Bacteroides fragilis | 1 | 2023 | 5 | 0.050 |
Why?
|
| Bacteroides | 1 | 2023 | 9 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 743 | 0.050 |
Why?
|
| Indoles | 1 | 2004 | 107 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2004 | 287 | 0.050 |
Why?
|
| Yersinia | 1 | 2003 | 3 | 0.050 |
Why?
|
| Porphyromonas gingivalis | 1 | 2003 | 16 | 0.050 |
Why?
|
| Digestive System | 1 | 2003 | 26 | 0.050 |
Why?
|
| Toll-Like Receptors | 1 | 2005 | 425 | 0.050 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2003 | 19 | 0.050 |
Why?
|
| Enterocytes | 1 | 2003 | 24 | 0.050 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 1999 | 18 | 0.050 |
Why?
|
| Respiratory Burst | 1 | 2002 | 19 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1479 | 0.050 |
Why?
|
| Lactoferrin | 1 | 2002 | 36 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 428 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 53 | 0.050 |
Why?
|
| Peroxidase | 1 | 2002 | 70 | 0.050 |
Why?
|
| Carbapenems | 1 | 2022 | 6 | 0.050 |
Why?
|
| Prebiotics | 1 | 2022 | 14 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2022 | 25 | 0.050 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 38 | 0.050 |
Why?
|
| Phospholipase D | 1 | 2001 | 6 | 0.050 |
Why?
|
| Bacteriocins | 1 | 2022 | 18 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 660 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1547 | 0.050 |
Why?
|
| Klebsiella pneumoniae | 1 | 2022 | 26 | 0.050 |
Why?
|
| Flavonoids | 1 | 2002 | 73 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 286 | 0.050 |
Why?
|
| Weight Gain | 1 | 2022 | 163 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 983 | 0.050 |
Why?
|
| Serotyping | 3 | 2005 | 50 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2001 | 137 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2003 | 324 | 0.040 |
Why?
|
| Proton Pump Inhibitors | 1 | 2021 | 34 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2000 | 45 | 0.040 |
Why?
|
| Pregnancy | 1 | 2007 | 2202 | 0.040 |
Why?
|
| Microglia | 1 | 2023 | 230 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2022 | 1464 | 0.040 |
Why?
|
| DNA Primers | 1 | 2000 | 289 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 128 | 0.040 |
Why?
|
| Clostridium septicum | 1 | 2019 | 1 | 0.040 |
Why?
|
| Eukaryotic Cells | 1 | 2000 | 57 | 0.040 |
Why?
|
| Dysentery | 1 | 1999 | 1 | 0.040 |
Why?
|
| Escherichia coli O157 | 1 | 1999 | 20 | 0.040 |
Why?
|
| Cell Size | 1 | 1999 | 40 | 0.040 |
Why?
|
| Antigens, Bacterial | 1 | 2000 | 200 | 0.040 |
Why?
|
| Lysine | 1 | 1999 | 74 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 189 | 0.040 |
Why?
|
| Monocytes | 1 | 2021 | 343 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 2372 | 0.040 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1998 | 1 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2022 | 914 | 0.040 |
Why?
|
| Lipoxins | 1 | 1998 | 7 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2018 | 39 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2003 | 696 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 1999 | 178 | 0.040 |
Why?
|
| Rabbits | 1 | 1999 | 322 | 0.040 |
Why?
|
| Biomarkers | 1 | 2023 | 1305 | 0.040 |
Why?
|
| Receptors, Interleukin-8A | 1 | 1998 | 4 | 0.040 |
Why?
|
| Receptors, Formyl Peptide | 1 | 1998 | 6 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 455 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 1998 | 20 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2000 | 332 | 0.040 |
Why?
|
| Superoxides | 1 | 1998 | 69 | 0.040 |
Why?
|
| Receptors, Interleukin | 1 | 1998 | 39 | 0.040 |
Why?
|
| Receptors, Peptide | 1 | 1998 | 31 | 0.040 |
Why?
|
| Disk Diffusion Antimicrobial Tests | 1 | 2017 | 1 | 0.040 |
Why?
|
| Gene Order | 1 | 2017 | 29 | 0.040 |
Why?
|
| Lymphocytes | 1 | 1998 | 190 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 1998 | 176 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 1252 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 2017 | 156 | 0.030 |
Why?
|
| Antigens, CD | 1 | 1998 | 341 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 837 | 0.030 |
Why?
|
| United States | 2 | 2019 | 7385 | 0.030 |
Why?
|
| Ceramides | 1 | 2016 | 25 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 559 | 0.030 |
Why?
|
| Gene Expression | 3 | 2004 | 808 | 0.030 |
Why?
|
| Medicare | 1 | 2019 | 598 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 1995 | 207 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 163 | 0.030 |
Why?
|
| Obesity | 1 | 2022 | 1166 | 0.030 |
Why?
|
| Shiga Toxin | 1 | 2014 | 4 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2018 | 841 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2001 | 1470 | 0.030 |
Why?
|
| Genes, Switch | 1 | 1993 | 6 | 0.030 |
Why?
|
| Europe | 1 | 2013 | 184 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2013 | 61 | 0.030 |
Why?
|
| Operon | 1 | 1993 | 31 | 0.030 |
Why?
|
| Chromosome Inversion | 1 | 1993 | 17 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2013 | 101 | 0.030 |
Why?
|
| Phagocytosis | 2 | 2005 | 249 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2012 | 47 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2013 | 170 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2012 | 381 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 238 | 0.020 |
Why?
|
| Mannose | 1 | 1989 | 21 | 0.020 |
Why?
|
| Sulfides | 1 | 1989 | 23 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 1989 | 34 | 0.020 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2008 | 4 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 1988 | 47 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2008 | 112 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 4266 | 0.020 |
Why?
|
| Culture Media | 1 | 1988 | 77 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 248 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 6071 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 5283 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 5822 | 0.020 |
Why?
|
| Multigene Family | 1 | 2007 | 92 | 0.020 |
Why?
|
| Iron-Binding Proteins | 1 | 2006 | 8 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2006 | 24 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2006 | 102 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2008 | 229 | 0.020 |
Why?
|
| Receptors, CCR6 | 1 | 2006 | 10 | 0.020 |
Why?
|
| Cysteine | 1 | 2006 | 107 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 356 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 147 | 0.020 |
Why?
|
| STAT6 Transcription Factor | 1 | 2005 | 7 | 0.020 |
Why?
|
| Queensland | 1 | 2005 | 1 | 0.020 |
Why?
|
| Chemokines, CX3C | 1 | 2005 | 3 | 0.020 |
Why?
|
| Chemokine CX3CL1 | 1 | 2005 | 5 | 0.020 |
Why?
|
| Ileum | 1 | 2005 | 19 | 0.010 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2005 | 10 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 2005 | 54 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 209 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2005 | 230 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2005 | 174 | 0.010 |
Why?
|
| Intestine, Small | 1 | 2005 | 76 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2006 | 639 | 0.010 |
Why?
|
| Swine | 1 | 2005 | 352 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2005 | 244 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 495 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2005 | 300 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 2004 | 126 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 352 | 0.010 |
Why?
|
| HT29 Cells | 1 | 2003 | 28 | 0.010 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2003 | 26 | 0.010 |
Why?
|
| Caco-2 Cells | 1 | 2003 | 66 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 295 | 0.010 |
Why?
|
| Symbiosis | 1 | 2003 | 29 | 0.010 |
Why?
|
| Zonula Occludens-2 Protein | 1 | 2002 | 2 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 653 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 1093 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 15663 | 0.010 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2001 | 21 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 1136 | 0.010 |
Why?
|
| Citric Acid Cycle | 1 | 2000 | 26 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2000 | 70 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 2000 | 48 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2000 | 73 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2000 | 89 | 0.010 |
Why?
|
| Endocytosis | 1 | 2001 | 148 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2000 | 288 | 0.010 |
Why?
|
| Cattle | 1 | 2000 | 304 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1998 | 67 | 0.010 |
Why?
|
| Integrins | 1 | 1998 | 106 | 0.010 |
Why?
|
| Drug Stability | 1 | 1998 | 141 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2004 | 623 | 0.010 |
Why?
|
| Kinetics | 1 | 1998 | 750 | 0.010 |
Why?
|
| Proteins | 1 | 2002 | 730 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1998 | 648 | 0.010 |
Why?
|
| Child | 1 | 2003 | 4173 | 0.010 |
Why?
|